600062.SH
华润双鹤
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.83
+1.02%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 10.7B | 11.0B | 11.2B | 11.3B | 9.6B |
| Cost of Revenue | 4.6B | 4.6B | 4.8B | 4.9B | 4.3B |
| Gross Profit | 6.2B | 6.4B | 6.4B | 6.4B | 5.3B |
| Operating Expenses | |||||
| R&D Expense | 526.7M | 531.6M | 555.2M | 627.8M | 482.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 960.9M | 966.9M | 961.0M | 872.3M | 752.1M |
| Selling & Marketing Expense | 2.9B | 3.1B | 3.2B | 3.1B | 2.7B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 4.6B | 4.7B | 4.8B | 4.7B | 4.0B |
| Cost and Expenses | 9.1B | 9.3B | 9.6B | 9.5B | 8.3B |
| Operating Income (EBIT) | 1.8B | 1.9B | 1.8B | 1.9B | 1.4B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 1.9B | 1.9B | 1.9B | 1.9B | 1.4B |
| Income Tax Expense | 193.7M | 227.5M | 215.9M | 272.7M | 201.3M |
| Bottom Line | |||||
| Net Income | 1.6B | 1.6B | 1.6B | 1.7B | 1.2B |
| Earnings from Cont. Ops | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 1.6B | 1.6B | 1.6B | 1.7B | 1.2B |
| Per Share | |||||
| Basic EPS | CN¥1.58 | CN¥1.59 | CN¥1.58 | CN¥1.63 | CN¥1.14 |
| Diluted EPS | CN¥1.58 | CN¥1.59 | CN¥1.58 | CN¥1.63 | CN¥1.14 |
| Revenue Per Share | CN¥10.39 | CN¥10.65 | CN¥10.91 | CN¥11.04 | CN¥9.30 |
| Shares | |||||
| Basic Shares Outstanding | 1.0B | 1.0B | 1.0B | 1.0B | 1.0B |
| Diluted Shares Outstanding | 1.0B | 1.0B | 1.0B | 1.0B | 1.0B |
| Profitability Metrics | |||||
| EBITDA | — | 2.6B | 2.6B | 2.6B | 2.0B |
| D&A | — | 771.6M | 734.9M | 669.8M | 544.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026